Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life

Abstract

This retrospective analysis suggests that CSII improves metabolic control in Type 1 diabetic patients, reduces hypoglycaemic and ketoacidotic events, is well accepted, allows a good quality of life and decreases out-patient consultations and hospital admissions.